• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估利什曼病治愈者体内干扰素-γ水平和利什曼菌素皮肤试验结果。

Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.

机构信息

Immunology Department, Pasteur Institute of Iran, Tehran, Iran.

出版信息

Am J Trop Med Hyg. 2012 Jul;87(1):70-5. doi: 10.4269/ajtmh.2012.11-0479.

DOI:10.4269/ajtmh.2012.11-0479
PMID:22764294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3391060/
Abstract

Patients who recover from leishmaniasis usually show development of strong immunity and induction of interferon-γ (IFN-γ) and delayed type hypersensitivity. In a randomized trial, we analyzed the IFN-γ response by using a Quantiferon-Leishmania assay against three Leishmania peptide antigens and compared it with results of the leishmanin skin test (LST) in persons residing in areas in Iran to which zoonotic cutaneous leishmaniasis (ZCL, 181 persons), anthroponotic cutaneous leishmaniasis (ACL, 104 persons), and zoonotic visceral leishmaniasis (ZVL, 67 persons) are endemic. The percentage of persons with an IFN-γ-positive response (> 0.2 IU/mL) to three antigens and the mean concentration of IFN-γ induced by the antigens were higher for persons from areas endemic for ZVL than for persons from areas endemic for ZCL and ACL. The percentage of persons with LST-positive results (≥ 5 mm indurations) was 99%, 94%, and 70% for areas with ZCL, ACL, and ZVL, respectively. Our data indicate that the LST is significantly more sensitive than IFN-γ levels in persons who have been cured of cutaneous leishmaniasis than in persons who have been cured of ZVL.

摘要

患有利什曼病并痊愈的患者通常会产生强烈的免疫反应,引起干扰素-γ(IFN-γ)和迟发型超敏反应。在一项随机试验中,我们分析了用利什曼原虫抗原检测试剂盒检测三种利什曼原虫肽抗原的 IFN-γ 反应,并将其与伊朗利什曼原虫病(ZCL,181 人)、人利什曼原虫病(ACL,104 人)和内脏利什曼原虫病(ZVL,67 人)流行地区居民的利什曼菌素皮肤试验(LST)结果进行了比较。对三种抗原的 IFN-γ 阳性反应(>0.2IU/mL)的人数百分比和抗原诱导的 IFN-γ 的平均浓度在 ZVL 流行地区的居民中均高于 ZCL 和 ACL 流行地区的居民。LST 阳性结果(≥5mm硬结)的人数百分比分别为 ZCL、ACL 和 ZVL 地区的 99%、94%和 70%。我们的数据表明,与已治愈的皮肤利什曼病患者相比,LST 在已治愈的内脏利什曼病患者中具有更高的敏感性。

相似文献

1
Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.评估利什曼病治愈者体内干扰素-γ水平和利什曼菌素皮肤试验结果。
Am J Trop Med Hyg. 2012 Jul;87(1):70-5. doi: 10.4269/ajtmh.2012.11-0479.
2
Dichotomy of protective cellular immune responses to human visceral leishmaniasis.对人类内脏利什曼病的保护性细胞免疫反应二分法。
Clin Exp Immunol. 2005 May;140(2):349-53. doi: 10.1111/j.1365-2249.2005.02768.x.
3
Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.突尼斯有症状或无症状的硕大利什曼原虫感染后的利什曼原虫皮肤试验淋巴细胞增殖反应及细胞因子产生
Clin Exp Immunol. 1999 Apr;116(1):127-32. doi: 10.1046/j.1365-2249.1999.00844.x.
4
Comparison of leishmanin skin test and direct smear for the diagnosis of cutaneous leishmaniasis.用于诊断皮肤利什曼病的利什曼原虫素皮肤试验与直接涂片法的比较。
Acta Med Iran. 2011;49(3):136-41.
5
Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection.利用 QFT-Leishmania 作为评估利什曼原虫感染暴露的流行病学工具。
Am J Trop Med Hyg. 2010 Oct;83(4):822-4. doi: 10.4269/ajtmh.2010.09-0605.
6
Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina.利什曼素皮肤试验(LST)在美洲皮肤利什曼病治疗中的再评估:阿根廷参考中心的回顾性分析。
PLoS Negl Trop Dis. 2017 Oct 5;11(10):e0005980. doi: 10.1371/journal.pntd.0005980. eCollection 2017 Oct.
7
Immunity Against Infection: Parasite-Specific Granzyme B Induction as a Correlate of Protection.抗感染免疫:寄生虫特异性颗粒酶 B 的诱导作为保护相关性的指标。
Front Cell Infect Microbiol. 2018 Nov 13;8:397. doi: 10.3389/fcimb.2018.00397. eCollection 2018.
8
Age related efficiency of the leishmanin skin test as a marker of immunity to human visceral leishmaniasis.作为人类内脏利什曼病免疫标志物的利什曼原虫皮肤试验与年龄相关的效率
Arch Inst Pasteur Tunis. 2012;89(1-4):23-31.
9
A review of the leishmanin skin test: A neglected test for a neglected disease.利什曼素皮试评价:被忽视疾病的被忽视检测。
PLoS Negl Trop Dis. 2021 Jul 22;15(7):e0009531. doi: 10.1371/journal.pntd.0009531. eCollection 2021 Jul.
10
The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis.自然获得的对利什曼原虫素的迟发型超敏反应在抵抗与硕大利什曼原虫相关的皮肤利什曼病中的预测效度。
J Infect Dis. 2005 Dec 1;192(11):1981-7. doi: 10.1086/498042. Epub 2005 Oct 21.

引用本文的文献

1
Comparative Analysis of Microscopy, Leishmanin Skin Test (LST), and Direct Agglutination Test (DAT) for the Diagnosis of Human Cutaneous Leishmaniasis.用于诊断人类皮肤利什曼病的显微镜检查、利什曼原虫皮肤试验(LST)和直接凝集试验(DAT)的比较分析
Iran J Parasitol. 2025 Jan-Mar;20(1):13-20. doi: 10.18502/ijpa.v20i1.18101.
2
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis.记忆T细胞:评估抗利什曼病保护作用和疫苗效力的有前景的生物标志物。
Front Immunol. 2024 Feb 26;15:1304696. doi: 10.3389/fimmu.2024.1304696. eCollection 2024.
3
A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.CD4+ T 细胞亚群在皮肤利什曼病和内脏利什曼病免疫反应发展中的作用的历史性回顾。
Iran Biomed J. 2022 Mar 1;26(2):99-109. doi: 10.52547/ibj.26.2.99.
4
A review of the leishmanin skin test: A neglected test for a neglected disease.利什曼素皮试评价:被忽视疾病的被忽视检测。
PLoS Negl Trop Dis. 2021 Jul 22;15(7):e0009531. doi: 10.1371/journal.pntd.0009531. eCollection 2021 Jul.
5
Potential biomarkers of immune protection in human leishmaniasis.人体利什曼病免疫保护的潜在生物标志物。
Med Microbiol Immunol. 2021 Jun;210(2-3):81-100. doi: 10.1007/s00430-021-00703-8. Epub 2021 May 2.
6
Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation.全血刺激试验作为埃塞俄比亚 VL 患者治疗结局监测工具的初步评估
J Immunol Res. 2020 Jan 23;2020:8385672. doi: 10.1155/2020/8385672. eCollection 2020.
7
Cellular Markers of Active Disease and Cure in Different Forms of -Induced Disease.不同形式的自身免疫性疾病中活动性疾病和治愈的细胞标志物。
Front Cell Infect Microbiol. 2018 Nov 13;8:381. doi: 10.3389/fcimb.2018.00381. eCollection 2018.
8
Predominance of Leishmania major and rare occurrence of Leishmania tropica with haplotype variability at the center of Iran.伊朗中部利什曼原虫优势种为利什曼原虫和罕见的利什曼原虫热带种,存在单倍型变异。
Braz J Infect Dis. 2018 Jul-Aug;22(4):278-287. doi: 10.1016/j.bjid.2018.07.005. Epub 2018 Aug 13.
9
Cutaneous leishmaniasis: recent developments in diagnosis and management.皮肤利什曼病:诊断与管理的最新进展
Am J Clin Dermatol. 2015 Apr;16(2):99-109. doi: 10.1007/s40257-015-0114-z.
10
NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.感染墨西哥利什曼原虫的局限性和弥漫性皮肤利什曼病患者的自然杀伤细胞活性存在差异:Toll样受体和细胞因子的比较研究
PLoS One. 2014 Nov 14;9(11):e112410. doi: 10.1371/journal.pone.0112410. eCollection 2014.

本文引用的文献

1
CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.CD8+ T 细胞作为人类皮肤利什曼病 IFN-γ 产生的来源。
PLoS Negl Trop Dis. 2010 Oct 12;4(10):e845. doi: 10.1371/journal.pntd.0000845.
2
Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection.利用 QFT-Leishmania 作为评估利什曼原虫感染暴露的流行病学工具。
Am J Trop Med Hyg. 2010 Oct;83(4):822-4. doi: 10.4269/ajtmh.2010.09-0605.
3
T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.针对利什曼原虫和其他非相关微生物抗原的 T 细胞可以迁移到人类利什曼病皮肤损伤处。
J Invest Dermatol. 2010 May;130(5):1329-36. doi: 10.1038/jid.2009.428. Epub 2010 Jan 28.
4
Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.人源皮肤利什曼病中对利什曼原虫抗原的免疫反应
J Infect. 2009 Aug;59(2):139-43. doi: 10.1016/j.jinf.2009.05.010. Epub 2009 Jun 6.
5
Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.Th1/Th2免疫反应与活动性皮肤利什曼病相关,而临床治愈与强烈的γ干扰素产生相关。
Hum Immunol. 2009 Jun;70(6):383-90. doi: 10.1016/j.humimm.2009.01.007. Epub 2009 Jan 20.
6
First generation leishmaniasis vaccines: a review of field efficacy trials.第一代利什曼病疫苗:现场效力试验综述
Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23.
7
Exposure to Leishmania major modulates the proportion of CD4+ T cells without affecting cellular immune responses.
Microbiol Immunol. 2007;51(10):1003-11. doi: 10.1111/j.1348-0421.2007.tb03984.x.
8
Cutaneous leishmaniasis.皮肤利什曼病
Lancet Infect Dis. 2007 Sep;7(9):581-96. doi: 10.1016/S1473-3099(07)70209-8.
9
Leishmania major: genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer.硕大利什曼原虫:通过单链构象多态性和核糖体DNA内转录间隔区序列分析对伊朗分离株的遗传异质性研究
Acta Trop. 2006 Apr;98(1):52-8. doi: 10.1016/j.actatropica.2006.01.010. Epub 2006 Mar 2.
10
Advances in leishmaniasis.利什曼病的研究进展
Lancet. 2005;366(9496):1561-77. doi: 10.1016/S0140-6736(05)67629-5.